These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33765190)

  • 1. Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting.
    Bayle A; Droin N; Besse B; Zou Z; Boursin Y; Rissel S; Solary E; Lacroix L; Rouleau E; Borget I; Bonastre J
    Eur J Health Econ; 2021 Aug; 22(6):855-864. PubMed ID: 33765190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
    Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
    Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Exome Sequencing (WES) for Illumina Short Read Sequencers Using Solution-Based Capture.
    Mahajan MC; McLellan AS
    Methods Mol Biol; 2020; 2076():85-108. PubMed ID: 31586323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
    Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
    Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing in intellectual disability; cost before and after a diagnosis.
    Vrijenhoek T; Middelburg EM; Monroe GR; van Gassen KLI; Geenen JW; Hövels AM; Knoers NV; van Amstel HKP; Frederix GWJ
    Eur J Hum Genet; 2018 Nov; 26(11):1566-1571. PubMed ID: 29959382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.
    Soilly AL; Robert-Viard C; Besse C; Bruel AL; Gerard B; Boland A; Piton A; Duffourd Y; Muller J; Poë C; Jouan T; El Doueiri S; Faivre L; Bacq-Daian D; Isidor B; Genevieve D; Odent S; Philip N; Doco-Fenzy M; Lacombe D; Asensio ML; Deleuze JF; Binquet C; ; Thauvin-Robinet C; Lejeune C
    BMC Health Serv Res; 2023 Apr; 23(1):386. PubMed ID: 37085862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
    Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
    Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
    Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
    J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data.
    Salma M; Alaterre E; Moreaux J; Soler E
    Epigenetics Chromatin; 2023 Jun; 16(1):23. PubMed ID: 37312221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the costs of genomic sequencing in cancer control.
    Gordon LG; White NM; Elliott TM; Nones K; Beckhouse AG; Rodriguez-Acevedo AJ; Webb PM; Lee XJ; Graves N; Schofield DJ
    BMC Health Serv Res; 2020 Jun; 20(1):492. PubMed ID: 32493298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children.
    Aaltio J; Hyttinen V; Kortelainen M; Frederix GWJ; Lönnqvist T; Suomalainen A; Isohanni P
    Eur J Paediatr Neurol; 2022 Jan; 36():30-36. PubMed ID: 34852981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities.
    Tetreault M; Bareke E; Nadaf J; Alirezaie N; Majewski J
    Expert Rev Mol Diagn; 2015 Jun; 15(6):749-60. PubMed ID: 25959410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added Value of Whole-Exome and Transcriptome Sequencing for Clinical Molecular Screenings of Advanced Cancer Patients With Solid Tumors.
    Koeppel F; Bobard A; Lefebvre C; Pedrero M; Deloger M; Boursin Y; Richon C; Chen-Min-Tao R; Robert G; Meurice G; Rouleau E; Michiels S; Massard C; Scoazec JY; Solary E; Soria JC; André F; Lacroix L
    Cancer J; 2018; 24(4):153-162. PubMed ID: 30119077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data.
    Zare F; Dow M; Monteleone N; Hosny A; Nabavi S
    BMC Bioinformatics; 2017 May; 18(1):286. PubMed ID: 28569140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole Exome Library Construction for Next Generation Sequencing.
    Liang WS; Stephenson K; Adkins J; Christofferson A; Helland A; Cuyugan L; Keats JJ
    Methods Mol Biol; 2018; 1706():163-174. PubMed ID: 29423798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
    Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815
    [No Abstract]   [Full Text] [Related]  

  • 19. Implementation of exome sequencing in fetal diagnostics-Data and experiences from a tertiary center in Denmark.
    Becher N; Andreasen L; Sandager P; Lou S; Petersen OB; Christensen R; Vogel I
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):783-790. PubMed ID: 32304219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
    Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
    Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.